| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Revenue | $463.5M | -13.4% |
| Cost of Revenue | $191.6M | -11.7% |
| Gross Profit | $271.8M | -14.5% |
| R&D Expense | $141.8M | +15.8% |
| SG&A Expense | $111.6M | +8.5% |
| Operating Income | -$148.0M | -182.6% |
| Pre-tax Income | -$146.8M | -162.5% |
| Income Tax | -$32.3M | -100.3% |
| Net Income | -$114.5M | -187.8% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.5M | -35.0% |
| Accounts Receivable | $72.6M | -15.8% |
| Inventory | $620K | +22.8% |
| Current Assets | $234.3M | -29.7% |
| Total Assets | $840.9M | -14.8% |
| Current Liabilities | $245.6M | -7.8% |
| Total Liabilities | $282.9M | -16.6% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.6M | -474.0% |
| Capital Expenditures | $1.9M | +1.0% |
| Investing Cash Flow | -$5.7M | +29.5% |
| Financing Cash Flow | -$8.9M | -6.2% |
| Free Cash Flow | -$64.5M | -535.9% |
| Stockholders' Equity |
| $558.0M |
| -13.9% |